课题基金 / 基金详情

Training Program in Translational Research in Cancer

Training Program in Translational Research in Cancer
癌症转化研究培训计划
批准号:
7270518
负责人:
EDMUND C. LATTIME
金额:
$21.82万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2009-10-31

项目摘要

项目成果

EDMUND C. LATTIME的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):成功完成转化研究需要将基础科学实验室研究的最高质量与对发现的临床转化的独特要求的基本理解相结合。 为了最有效地将基础研究成果转化为临床研究成果,应在研究开发的各个层面考虑对此类举措的临床要求的理解,而不是将其作为基础实验室开发的复杂补充。 这个翻译研究的培训计划专注于这种整合。 该博士后培训计划的主要目标是为候选人提供最高质量的培训和研究经验,使他们在学术界,政府和私营部门发展研究事业方面具有竞争力。 该项目旨在培养博士后研究员(均为医学博士)(PhD)在临床上重要的诊断和治疗策略的开发和测试中。 作为第一优先事项,研究员将在高度关键和成功的实验室接受培训,以确保最高水平的科学严谨性。 此外,选修课程和研讨会讨论系列已被设计成专注于基础科学发现的临床翻译的独特要求。 博士后研究员将有望参加临床相关课程,并参加研讨会讨论系列。 教师已从我们正在进行的科学计划的基础上选择:1。最高质量的研究; 2。其翻译研究活动;和3。他们致力于在新泽西癌症研究所(CINJ)的背景下进行合作研究。 所有为这个项目选择的导师都符合这三个标准。 博士后候选人将是博士。希望在临床相关研究或医学博士领域发展事业的持有人(M.D./博士)完成他们的培训(在他们的临床奖学金)谁希望在学术医学的职业生涯做准备。 博士后计划的毕业生将有望成为学术教师职位的竞争力,并应在R 01级的入门级资金奖的竞争力。
英文摘要
DESCRIPTION (provided by applicant): The successful accomplishment of translational research requires a combination of the highest quality of basic science laboratory studies with a fundamental understanding of the unique requirements of clinical translation of the discoveries. In order to achieve the most efficient translation of basic findings to the clinic, the appreciation of the clinical requirements of such a move should be considered at all levels of research development rather than as a complicating afterthought to the basic laboratory development. This training program in translational research focuses on just this integration. The primary objective of this postdoctoral training program in translational cancer research is to provide candidates with the highest quality training and research experience so that they will be competitive in developing research careers in academia, government, and the private sector. This program has been designed to train postdoctoral fellows (both M.D. and Ph.D.) in the development and testing of clinically important diagnostic and therapeutic strategies. As the first priority, fellows will be trained in highly critical and successful laboratories to assure the highest level of scientific rigor. In addition, elective courses and seminar discussion series have been designed to focus on the unique requirements for clinical translation of the basic science findings. Postdoctoral fellows will be expected to take part in both the clinically relevant courses and participate in the seminar discussion series. Faculty has been chosen from our ongoing science programs based on: 1. The highest quality of their research; 2. Their translational research activities; and 3. Their commitment to collaborative research in the context of The Cancer Institute of New Jersey (CINJ). All of the preceptors chosen for this program meet these three criteria. Postdoctoral candidates will be either Ph.D. holders who wish to develop careers in clinically relevant research or M.D. (M.D./Ph.D.) finishing their training (following their clinical fellowships) who wish to prepare for careers in academic medicine. Graduates of the postdoctoral program will be expected to be competitive for academic faculty positions and should be competitive for entry level funding awards at the R01 level.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
TAS::75 0849::TAS
TAS::75 0849::TAS
Fluorescence Activated Cell Sorter
TGFBeta Receptor Mutations in Cancer and Other Diseases
海外基金